Aurora Cannabis (TSE:ACB) Price Target Cut to C$5.00 by Analysts at Canaccord Genuity Group

Aurora Cannabis (TSE:ACB – Get Free Report) had its target price decreased by equities research analysts at Canaccord Genuity Group from C$6.50 to C$5.00 in a research note issued to investors on Tuesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target points to a potential upside of 26.26% from the stock’s previous close.

Separately, TD decreased their target price on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of C$7.17.

Get Aurora Cannabis alerts:

Read Our Latest Stock Analysis on Aurora Cannabis

Aurora Cannabis Stock Performance

ACB stock traded down C$0.16 during trading on Tuesday, hitting C$3.96. 326,585 shares of the company’s stock traded hands, compared to its average volume of 410,117. The stock has a market capitalization of C$245.29 million, a price-to-earnings ratio of -1.85 and a beta of 0.17. Aurora Cannabis has a 52 week low of C$3.77 and a 52 week high of C$9.33. The stock has a fifty day moving average price of C$4.60 and a two-hundred day moving average price of C$5.12. The company has a quick ratio of 2.48, a current ratio of 5.94 and a debt-to-equity ratio of 4.66.

Aurora Cannabis (TSE:ACB – Get Free Report) last announced its quarterly earnings data on Thursday, June 11th. The company reported C($0.99) earnings per share for the quarter. The business had revenue of C$38.01 million for the quarter. Aurora Cannabis had a negative net margin of 12.13% and a negative return on equity of 7.25%. As a group, equities analysts anticipate that Aurora Cannabis will post -0.22 EPS for the current fiscal year.

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Recommended Stories

• Five stocks we like better than Aurora Cannabis
• Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
• AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
• These 3 Dividend Stocks Could Boost Your Income This July
• Rocket Lab Defies Gravity With $8B Buyout

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.